Published in J Biol Chem on February 20, 1998
Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev (2000) 5.53
The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes. Endocr Rev (2008) 3.56
Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem J (1998) 2.65
Expression profiling of pancreatic beta cells: glucose regulation of secretory and metabolic pathway genes. Proc Natl Acad Sci U S A (2000) 1.46
Nicotinic acid-adenine dinucleotide phosphate-sensitive calcium stores initiate insulin signaling in human beta cells. Proc Natl Acad Sci U S A (2002) 1.29
Metabotropic glutamate receptor-initiated translocation of protein kinase p90rsk to polyribosomes: a possible factor regulating synaptic protein synthesis. Proc Natl Acad Sci U S A (1998) 1.28
Plasticity of the beta cell insulin secretory competence: preparing the pancreatic beta cell for the next meal. J Physiol (2004) 1.12
Nutrients differentially regulate multiple translation factors and their control by insulin. Biochem J (1999) 1.11
Amino-acid-dependent signal transduction. Biochem J (2000) 1.09
Glucose exerts a permissive effect on the regulation of the initiation factor 4E binding protein 4E-BP1. Biochem J (2001) 0.97
Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantation. J Transl Med (2007) 0.94
mTORC1 signaling and regulation of pancreatic β-cell mass. Cell Cycle (2012) 0.94
A small molecule differentiation inducer increases insulin production by pancreatic β cells. Proc Natl Acad Sci U S A (2011) 0.92
Glucose and amino acids modulate translation factor activation by growth factors in PC12 cells. Biochem J (2000) 0.91
Therapeutic Strategies to Increase Human β-Cell Growth and Proliferation by Regulating mTOR and GSK-3/β-Catenin Pathways. Open Endocrinol J (2010) 0.83
Differential Regulation of ERK1/2 and mTORC1 Through T1R1/T1R3 in MIN6 Cells. Mol Endocrinol (2015) 0.80
The selective recruitment of mRNA to the ER and an increase in initiation are important for glucose-stimulated proinsulin synthesis in pancreatic beta-cells. Biochem J (2005) 0.79
Phosphorylation and degradation of S6K1 (p70S6K1) in response to persistent JNK1 Activation. Biochim Biophys Acta (2013) 0.78
4E-BP2/SH2B1/IRS2 Are Part of a Novel Feedback Loop That Controls β-Cell Mass. Diabetes (2016) 0.75
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol (2001) 10.85
Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function. Nature (1994) 9.30
Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science (1997) 7.07
Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J (1996) 6.08
PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science (1994) 5.62
Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc Natl Acad Sci U S A (1998) 3.66
Heat balance and the metabolic rate of new-born babies in relation to environmental temperature; and the effect of age and of weight on basal metabolic rate. J Physiol (1965) 3.62
Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol (1993) 3.00
Construction and characterization of a conditionally active version of the serine/threonine kinase Akt. J Biol Chem (1998) 2.93
Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes (1992) 2.92
Control of PHAS-I by insulin in 3T3-L1 adipocytes. Synthesis, degradation, and phosphorylation by a rapamycin-sensitive and mitogen-activated protein kinase-independent pathway. J Biol Chem (1995) 2.83
Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J Immunol (1993) 2.73
Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression. Mol Cell Biol (2000) 2.35
Surgical management of multiple polyposis. The problem of cancer in the retained bowel segment. Arch Surg (1970) 2.31
A metabolite-regulated potassium channel in rat pancreatic B cells. Proc Natl Acad Sci U S A (1986) 2.27
Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc Natl Acad Sci U S A (1993) 2.24
Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid. Diabetes (2001) 2.21
Identification of phosphorylation sites in the translational regulator, PHAS-I, that are controlled by insulin and rapamycin in rat adipocytes. J Biol Chem (1997) 2.19
The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminus. J Biol Chem (1997) 2.16
Investigating the bacterial barrier properties of four contemporary wound dressings. J Wound Care (2000) 2.13
Evidence for the involvement of sulfhydryl oxidation in the regulation of fat cell hexose transport by insulin. Proc Natl Acad Sci U S A (1974) 2.06
Phosphorylation of PHAS-I by mitogen-activated protein (MAP) kinase. Identification of a site phosphorylated by MAP kinase in vitro and in response to insulin in rat adipocytes. J Biol Chem (1994) 2.06
Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci U S A (1993) 2.06
Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes (1992) 2.04
Molecular cloning and tissue distribution of PHAS-I, an intracellular target for insulin and growth factors. Proc Natl Acad Sci U S A (1994) 2.02
cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells. Proc Natl Acad Sci U S A (1995) 1.97
Ethnic differences in incidence of severe burns and scalds to children in Birmingham. BMJ (1989) 1.89
Branched-chain amino acids are essential in the regulation of PHAS-I and p70 S6 kinase by pancreatic beta-cells. A possible role in protein translation and mitogenic signaling. J Biol Chem (1998) 1.85
Mammalian target of rapamycin-dependent phosphorylation of PHAS-I in four (S/T)P sites detected by phospho-specific antibodies. J Biol Chem (2000) 1.83
Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. J Clin Invest (1992) 1.82
Preliminary characterization of calcium binding in islet-cell plasma membranes. Diabetologia (1980) 1.75
Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific protein phosphatase PP1G/RGL. Mol Cell Biol (2001) 1.73
Intracellular Ca2+ mobilization by arachidonic acid. Comparison with myo-inositol 1,4,5-trisphosphate in isolated pancreatic islets. J Biol Chem (1986) 1.70
Control of the translational regulators PHAS-I and PHAS-II by insulin and cAMP in 3T3-L1 adipocytes. J Biol Chem (1996) 1.69
Oxygen consumption in normally grown, small-for-dates and large-for-dates new-born infants. J Physiol (1968) 1.66
Honey and wound bacteria. J Wound Care (1999) 1.64
Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest (2002) 1.61
Interleukin-1 beta-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1 beta-induced inhibition of insulin secretion. J Biol Chem (1991) 1.59
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes (1993) 1.59
Attenuation of mammalian target of rapamycin activity by increased cAMP in 3T3-L1 adipocytes. J Biol Chem (1998) 1.54
Permeability of lung capillaries to macromolecules in foetal and new-born lambs and sheep. J Physiol (1969) 1.54
The routine proctoscopic examination: a second look. Mayo Clin Proc (1966) 1.51
Effects of sulfonamides on a metabolite-regulated ATPi-sensitive K+ channel in rat pancreatic B-cells. Am J Physiol (1989) 1.51
A subcellular fractionation approach for studying insulin release mechanisms and calcium metabolism in islets of Langerhans. Methods Enzymol (1983) 1.48
Metabolic regulation by leucine of translation initiation through the mTOR-signaling pathway by pancreatic beta-cells. Diabetes (2001) 1.42
Studies on the mechanism of resistance to rapamycin in human cancer cells. Mol Pharmacol (1998) 1.41
Factors in hospice patients' length of stay. Am J Hosp Palliat Care (1999) 1.40
Insulin stimulates protein synthesis in skeletal muscle by enhancing the association of eIF-4E and eIF-4G. Am J Physiol (1997) 1.40
Leucine and insulin activate p70 S6 kinase through different pathways in human skeletal muscle. Am J Physiol Endocrinol Metab (2001) 1.40
Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J Exp Med (1995) 1.40
Hexose transport in isolated brown fat cells. A model system for investigating insulin action on membrane transport. J Biol Chem (1974) 1.39
IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry (1993) 1.36
Rectal prolapse. Causation and surgical treatment. Ann Surg (1970) 1.35
Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction. Biochem J (1992) 1.34
Activation of glycogen synthase in rat adipocytes by insulin and glucose involves increased glucose transport and phosphorylation. J Biol Chem (1978) 1.32
The tangential excision of burns: an experimental study using an animal model. Injury (1971) 1.32
Regulation of both glycogen synthase and PHAS-I by insulin in rat skeletal muscle involves mitogen-activated protein kinase-independent and rapamycin-sensitive pathways. J Biol Chem (1996) 1.31
Inhibition of nitric oxide formation by guanidines. Eur J Pharmacol (1993) 1.31
Cytokines and nitric oxide in islet inflammation and diabetes. Proc Soc Exp Biol Med (1996) 1.29
Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochem Biophys Res Commun (1993) 1.29
Relative hypoglycemia and hyperinsulinemia in mice with heterozygous lipoprotein lipase (LPL) deficiency. Islet LPL regulates insulin secretion. J Biol Chem (1999) 1.28
Glucose-induced accumulation of inositol trisphosphates in isolated pancreatic islets. Predominance of the 1,3,4-isomer. Biochem J (1986) 1.25
Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans. Diabetes (1987) 1.23
Wound infection under occlusive dressings. J Hosp Infect (1991) 1.23
Hyperinsulinism in mice with heterozygous loss of K(ATP) channels. Diabetologia (2006) 1.22
Endometrial glands are required for preimplantation conceptus elongation and survival. Biol Reprod (2001) 1.20
Mitogen-activated protein kinase activation is not sufficient for stimulation of glucose transport or glycogen synthase in 3T3-L1 adipocytes. J Biol Chem (1993) 1.19
Evidence for electron transfer reactions involved in the Cu2+ -dependent thiol activation of fat cell glucose utilization. J Biol Chem (1974) 1.17
Human vascular endothelial cells synthesize and release 24- and 26-carbon polyunsaturated fatty acids. Biochim Biophys Acta (1984) 1.16
Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc Natl Acad Sci U S A (1993) 1.16
Cell-specific translational regulation of S-adenosylmethionine decarboxylase mRNA. Influence of the structure of the 5' transcript leader on regulation by the upstream open reading frame. J Biol Chem (1994) 1.15
What materials for dressings? Injury (1982) 1.14
Insulin and diabetes cause reciprocal changes in the association of eIF-4E and PHAS-I in rat skeletal muscle. Am J Physiol (1996) 1.14
The digitonin-permeabilized pancreatic islet model. Effect of myo-inositol 1,4,5-trisphosphate on Ca2+ mobilization. Biochem J (1985) 1.13
Alloxan uptake by isolated rat islets of Langerhans. Endocrinology (1978) 1.13
Increased glycogen accumulation in transgenic mice overexpressing glycogen synthase in skeletal muscle. Proc Natl Acad Sci U S A (1996) 1.13
Mutational analysis of sites in the translational regulator, PHAS-I, that are selectively phosphorylated by mTOR. FEBS Lett (1999) 1.13
The bacteriology of burns. J Hosp Infect (1985) 1.13
Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem (1996) 1.12
Alginate dressing as a donor site haemostat. Ann R Coll Surg Engl (1986) 1.12
Development and evaluation of an enzyme-linked immunosorbent assay for use in the detection of bovine tuberculosis in cattle. Clin Vaccine Immunol (2011) 1.11
Treating burns. J R Soc Med (1991) 1.11
Standardization fo a digestion-filtration method for isolation of pancreatic islets. Diabetes (1976) 1.11
Flutamide-hydroxypropy-beta-chiyclodextrin complex: formulation, physical characterization, and absorption studies using the Caco-2 in vitro model. J Pharm Pharm Sci (2000) 1.11
Mitogen-activated protein kinase-independent pathways mediate the effects of nerve growth factor and cAMP on neuronal survival. J Biol Chem (1996) 1.11